Jack Leonard

Jack Leonard has extensive experience in the biotechnology industry, currently serving as CTO and co-founder of seqWell Inc. since February 2014. Previously, Jack held the position of Vice President of Product Development at Pathogenica, where skills were utilized to lead the R&D team in the development and launch of the HAI BioDetection Kit. Additional roles include Vice President of Technology Commercialization at Febit, Inc., Director of R&D at Codon Devices, and R&D Director at US Genomics and Millipore, among others. Jack's career in research and development began with Amicon, INC, where significant contributions were made prior to its acquisition by Millipore. Jack holds a Ph.D. in Genetics from the University of Connecticut, earned between 1986 and 1991.